Complexoproductive and antiheparin properties of low density lipoproteins (LDL). VI. Antiheparin activity in blood plasma of different species of vertebrates.

This research investigates how the antiheparin activity in the blood plasma of different vertebrate species is largely dependent on the amounts of low density lipoproteins (LDL). Particularly, it suggests that higher antiheparin activity in chicken and human blood plasma correlates to higher LDL content while lower antiheparin activity in the blood plasma of horse, cow, sheep, dog and pig matches decreased amounts of LDL content.

Research Focus

• The study focuses on uncovering how the antiheparin activities vary in the blood plasma of different vertebrate species. Antiheparin activity pertains to an element’s ability to counteract the effect of heparin, a medication used as an anticoagulant to prevent blood clots.

Role of Low Density Lipoproteins

• The research reveals a substantial link between this activity and the content of Low Density Lipoproteins (LDL) in the blood plasma. LDL is a type of lipoprotein that contributes to cholesterol transport in the bloodstream.
• Findings point out that species with high concentrations of LDL, such as chickens and humans, correspondingly have high antiheparin activity in their blood plasma.
• Conversely, animals like horses, cows, sheep, dogs, and pigs, which have lower LDL concentrations, likewise exhibit lower antiheparin activity.

Importance of Other Elements

• The research additionally establishes that the influence of other elements on antiheparin activity is less significant.
• Differences in fibrinogen quantities, acid alfa1-glycoproteins, globulins, alkaline proteins, and antithrombin III activity resulted in only minor impacts on the antiheparin activity of the blood plasma from the animals studied.

Conclusions and Impact

• By highlighting an important relationship between LDL content and antiheparin activity across different species of vertebrates, this research could impact how species-specific medical treatments, especially those involving anticoagulants, are understood and developed.